Capital Analysts »

Silverback Therapeutics shares owned by Capital Analysts

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Capital Analysts from 13F filings

Historical chart of Capital Analysts investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Capital Analysts

Quarter filed Position value Share count Share price at filing
2025-12-31 $15k 1.3k 11.54
2025-09-30 $13k 1.3k 10.00
2025-06-30 $23k 1.3k 17.69
2025-03-31 $16k 1.3k 12.31